Anika Therapeutics, Inc. Deferred Revenue
Anika Therapeutics, Inc. (ANIK) had Deferred Revenue of $33.95 thousand as of 2015-09-30, per its 10-Q filed 2015-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2015-11-03
- 2015-09-30: Deferred Revenue, Current $33.95K.
- 2015-06-30: Deferred Revenue, Current $35.94K.
- 2015-03-31: Deferred Revenue, Current $139.53K.
- 2014-12-31: Deferred Revenue, Current $24.51K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2015-09-30 | $33.95K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $35.94K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $139.53K 10-Q · filed 2015-05-04 |
| 2014-12-31 | $24.51K 10-Q · filed 2015-11-03 |
| 2014-09-30 | $12.88K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $15.46K 10-Q · filed 2014-08-04 |
| 2014-03-31 | $46.41K 10-Q · filed 2014-05-05 |
| 2013-12-31 | $180.43K 10-K · filed 2015-03-13 |
| 2013-09-30 | $850.07K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.53M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $2.19M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $2.88M 10-K · filed 2014-03-13 |
| 2012-09-30 | $2.87M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $2.87M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $2.87M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $2.87M 10-K · filed 2013-03-14 |
| 2011-09-30 | $2.84M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $2.71M 10-Q/A · filed 2011-08-10 |
| 2010-12-31 | $2.70M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |